Delivery Order SPE2DB20D1100-SPE2DB25FD8C0
- Not listed
- The Defense Logistics Agency awarded a $17,711.36 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, representing a critical pharmaceutical commodity within the federal medical supply chain. This delivery...
- The Defense Logistics Agency awarded a $3,374.96 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization protection against measles, mumps, rubella, and varicella, commonly used within military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $24,814.95 to AmerisourceBergen Drug Corp for ProQuad vials on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded contract is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine indicated for prevention of measles, mumps, rubella, and varicella, representing a critical pharmaceutical supply for...
- The Defense Logistics Agency awarded a delivery order valued at $7,168.24 to AmerisourceBergen Drug Corp for ProQuad vials. This is a firm fixed-price, non-set-aside contract with a completion deadline of August 19, 2025, issued on July 29, 2025. ProQuad is a combination vaccine for measles, mumps, rubella, and varicella, essential for military medical readiness and troop health maintenance. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing the type of critical medical supply that...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $8,354.50 under a firm fixed-price contract. The award was made on July 25, 2025, with an ultimate completion date of August 15, 2025. This is a non-set-aside, competitively awarded delivery order, with performance to take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $1,687.48, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order for ProQuad vials valued at $3,374.96 to AmerisourceBergen Drug Corp on July 29, 2025, with a completion date of August 19, 2025. This firm fixed-price delivery order is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitively awarded contract. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella,...
- The Defense Logistics Agency awarded a $3,341.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on July 21, 2025, with an ultimate completion date of August 11, 2025. This competitive award, issued without set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. ProQuad is a combination vaccine protecting...
- The Defense Logistics Agency awarded a $33,086.60 delivery order to AmerisourceBergen Drug Corp for ProQuad vials under a firm fixed price contract. This non-set-aside award was issued on July 29, 2025, with an ultimate completion date of August 19, 2025. ProQuad is a combination vaccine that protects against measles, mumps, rubella, and varicella, making this a critical pharmaceutical supply for military medical readiness and vaccine administration programs across the Department of Defense. The...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD8C0Delivery Order
The Defense Logistics Agency awarded a $49,629.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 25, 2025. This is a competitively awarded, non-set-aside contract performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing a critical pharmaceutical commodity for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The contract reflects AmerisourceBergen's established role as a major federal pharmaceutical distributor with demonstrated capability to fulfill diverse medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.6k | 8/4/25 |